Category Archives: Press Release

Portage Biotech Announces Voluntary Delisting from the Canadian Securities Exchange

...

Portage Biotech Highlights First Patient Dosed in PRECIOUS-01 Study of PORT-3 for the Treatment of NY-ESO-1 Positive Solid Tumors

...

PORTAGE BIOTECH HIGHLIGHTS INITIATION OF THE INVINCIBLE TRIAL, A PHASE 2 EARLY STAGE BREAST CANCER STUDY FROM INTENSITY THERAPEUTICS

...

PORTAGE BIOTECH DIVESTS PORTAGE PHARMACEUTICALS LIMITED TO JUVENESCENCE LTD

...

PORTAGE ANNOUNCES FILING OF THIRD QUARTER FINANCIAL STATEMENTS

...

PORTAGE COMMENCES TRADING ON NASDAQ

...

PORTAGE BIOTECH PROVIDES RESEARCH AND DEVELOPMENT UPDATE AND ANNOUNCES NASDAQ LISTING APPROVAL

...

PORTAGE ANNOUNCES FILING OF Q1 INTERIM FINANCIAL STATEMENTS; CORRECTION TO SALVARX LOAN NOTE SETTLEMENT ANNOUNCEMENT

...

PORTAGE ISSUES COMMON SHARES AND WARRANTS IN SETTLEMENT OF SALVARX LOAN NOTE OBLIGATIONS

...

PORTAGE ANNOUNCES RELIANCE ON TEMPORARY REGULATORY RELIEF FOR FILING ANNUAL FINANCIAL STATEMENTS

...